Shingo Noura, Ryo Inada, Hitoshi Ojima, Takeshi Nagasaka, Hiroaki Tanioka, Yoshinori Munemoto, Yasuhiro Shimada, Keiichiro Ishibashi, Yoshiaki Shindo, Mototsugu Shimokawa, et al. QoL analysis: A randomized phase 3 study of sequential versus combination treatment in firstline chemotherapy for metastatic colorectal cancer-The C-cubed study. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 4
Meiko Nishimura, Takahiro Kogawa, Yuko Akaishi, Misato Ogata, Jun Masuda, Mitsuo Terada, Hitomi Sakai, Kazuki Nozawa, Sasagu Kurozumi, Takamichi Yokoe, et al. Clinical evaluation of the efficacy and liquid molecular analysis of abemaciclib rechallenge upon progression to abemaciclib combination therapies for ER-positive HER2-negative metastatic breast cancer patients. CANCER RESEARCH. 2022. 82. 4
Kazuki Takada, Shinkichi Takamori, Naoko Miura, Yasunori Shikada, Mototsugu Shimokawa. Reasons to Consider the COVID-19 Vaccination Status of Patients With Cancer When Analyzing Their COVID-19 Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021. 39. 35. 3996-3996
Kazuki Takada, Shinkichi Takamori, Naoko Miura, Yasunori Shikada, Mototsugu Shimokawa. Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study). European journal of cancer (Oxford, England : 1990). 2021. 157. 529-530
American Society of Clinical Oncology
, European Society for Medical Oncology
, International Biometric Society
, 日本計量生物学会
, 日本臨床腫瘍学会
, 日本臨床試験学会
, 日本がんサポーティブケア学会